Feb 11 (Reuters) - AbbVie sued the U.S. Department of Health and Human Services on Wednesday, challenging a decision by the Centers for Medicare & Medicaid Services to impose price controls for Botox ...
The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations. The list includes Botox and the GLP-1 drug Trulicity. Subscribe to read this ...
The rise of Botox has yet to see a plateau. And while the injection is most commonly associated with those in their mid 40s and 50s, millennials are finding new and interesting ways to maintain the no ...
AbbVie says Congress excluded Botox from price controls Lawsuit alleges multiple constitutional violations Botox contributes over 10% to AbbVie's annual revenue HHS declines to comment Feb 12 (Reuters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results